Search filters

List of works by Makoto Tahara

A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study ⬇️

scientific article published on February 15, 2012

A Pilot Study of Post-operative Radiotherapy with Concurrent Chemotherapy for High-risk Squamous Cell Carcinoma of the Cervical Esophagus ⬇️

scientific article published on February 18, 2011

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition)

scientific article published on 01 July 2019

Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases

scientific article

Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx ⬇️

scientific article published on March 24, 2012

Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patients.

scientific article published on 22 August 2012

Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia

scientific article published on 07 July 2011

Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies

scientific article published on 3 July 2012

KRAS mutations detected by the amplification refractory mutation system–Scorpion assays strongly correlate with therapeutic effect of cetuximab ⬇️

scientific article published on July 5, 2011

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer ⬇️

scientific article published on May 22, 2012

Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy ⬇️

scientific article published on October 14, 2011

Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use

scientific article published on 25 June 2019

Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC?

scientific article published on 27 October 2011

Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases.

scientific article

Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012.

scientific article published on 8 February 2018

Pharmacological and clinical profile of exemestane (Aromasin), a novel irreversible aromatase inhibitor ⬇️

scientific article published on October 1, 2003

Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

scientific article published on 3 November 2012

Phase I trial of chemoradiotherapy with the combination of S‐1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck ⬇️

scientific article published on 07 December 2010

Proton Beam Therapy for Unresectable Malignancies of the Nasal Cavity and Paranasal Sinuses ⬇️

scientific article published on October 18, 2010

Pulmonary tumor thrombotic microangiopathy associated with esophageal squamous cell carcinoma

scientific article

Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab

scientific article published on 21 May 2010

Tumor KRAS Status Predicts Responsiveness to Panitumumab in Japanese Patients with Metastatic Colorectal Cancer ⬇️

scientific article published on December 17, 2010

Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer ⬇️

scientific article published on December 24, 2010

[Two cases of KRAS wild-type unresectable or recurrent colorectal cancer effectively treated by cetuximab after progression of prior chemotherapy].

scientific article published in June 2009

Paulina is supported by:

About Paulina

Help